These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30446119)

  • 1. Polymeric fluorescent heparin as one-step FRET substrate of human heparanase.
    Sistla JC; Morla S; Alabbas AB; Kalathur RC; Sharon C; Patel BB; Desai UR
    Carbohydr Polym; 2019 Feb; 205():385-391. PubMed ID: 30446119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Robust, One-step FRET Assay for Human Heparanase.
    Sistla JC; Desai UR
    Bio Protoc; 2019 Sep; 9(17):e3356. PubMed ID: 33654855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
    Pala D; Rivara S; Mor M; Milazzo FM; Roscilli G; Pavoni E; Giannini G
    Glycobiology; 2016 Jun; 26(6):640-54. PubMed ID: 26762172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
    Elli S; Guerrini M
    Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new methods for determining the heparanase enzymatic activity.
    Melo CM; Tersariol IL; Nader HB; Pinhal MA; Lima MA
    Carbohydr Res; 2015 Aug; 412():66-70. PubMed ID: 26062789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
    Gandhi NS; Freeman C; Parish CR; Mancera RL
    Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase, heparin and the coagulation system in cancer progression.
    Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
    Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protease inhibitors by a fast fluorimetric assay.
    Doti N; Raimondo D; Sabatella M; Ruvo M
    Mol Biotechnol; 2013 Jun; 54(2):283-91. PubMed ID: 22684771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
    Gratz A; Götz C; Jose J
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultrasensitive FRET-based fluorescent low molecular weight heparin nanoprobe for quantifying heparanase activity.
    Gu Y; Peng L; Ding W; Wang Y; Zeng X
    Talanta; 2023 Mar; 254():124207. PubMed ID: 36549136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatographic enzymatic studies with on-line Beta-secretase immobilized enzyme reactor and 4-(4-dimethylaminophenylazo) benzoic acid/5-[(2-aminoethyl) amino] naphthalene-1-sulfonic acid peptide as fluorogenic substrate.
    De Simone A; Seidl C; Santos CA; Andrisano V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():108-14. PubMed ID: 24590190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Anticoagulant Heparins as Heparanase Inhibitors.
    Cassinelli G; Torri G; Naggi A
    Adv Exp Med Biol; 2020; 1221():493-522. PubMed ID: 32274724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
    Chhabra M; Ferro V
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.
    Schiemann S; Lühn S; Alban S
    Anal Biochem; 2012 Aug; 427(1):82-90. PubMed ID: 22579846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-heparanase activity of ultra-low-molecular-weight heparin produced by physicochemical depolymerization.
    Achour O; Poupard N; Bridiau N; Bordenave Juchereau S; Sannier F; Piot JM; Fruitier Arnaudin I; Maugard T
    Carbohydr Polym; 2016 Jan; 135():316-23. PubMed ID: 26453883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.